BioTime Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem …EON: Enhanced Online News (press release)This may permit the repair or replacement of a patient's damaged tissues and organs without the risk of transplant rejection….
Asbestos.comEarnings Preview: Bristol-Myers to report 4QCBS NewsThose include Yervoy for advanced melanoma and transplant rejection drug Nulojix, both approved in the US and Europe, and anti-clotting drug Eliquis. Eliquis was approved in the European U…
BioTime Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem …MarketWatch (press release)This may permit the repair or replacement of a patient's damaged tissues and organs without the risk of transplant rejection. BioTime, head…
Alexion Pharmaceuticals (ALXN) PT Raised to $84.00 by Oppenheimer (OPY)LocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeu…
Goldman Sachs (GS) Analysts Reaffirm a "Buy" Rating on Alexion Pharmaceuticals …LocalizedUSA… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including …
Reason Online (blog)Encouraging News on Human Embryonic Stem Cell TreatmentReason Online (blog)The injected cells attached with the patients' retinas and have shown no signs of producing tumors or transplant rejection after four months. Some of the…
Transplantation, Innate Alloimmunity: Primary Allograft Injury Leads to …openPR (press release)Part 2: Innate Immunity and Allograft Rejection. Baskent University/Pabst Science Publishers, 2011, 760 pages hardcover, ISBN 9783-89967-738-6 Pabst Scienc…
Smiles for the first US face transplant recipientKPLC-TVIn March 2010, Wiens became the only patient of the firstthree surgeries done in the US who did not suffer an acute rejection of thetransplant within the first six months. "It's hard to b…
Peds Liver Transplant Patients Tolerate Drug WithdrawalDoctors LoungeEight patients did not meet the primary end point because of an exclusion criteria violation (one patient), acute rejection (two patients), or indeterminate rejection (five patients)….
MedPage TodayIf Dad's the Liver Donor, Jr. May Not Need Immune SuppressantsMedPage TodayThey also were stable on a single immunosuppressive drug without any evidence of chronic or acute rejection or significant fibrosis on liver biopsy. In contrast…